These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Taneva SG; Todinova S; Andreeva T Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599 [TBL] [Abstract][Full Text] [Related]
5. Intercriteria analysis of calorimetric data of blood serum proteome. Krumova S; Todinova S; Mavrov D; Marinov P; Atanassova V; Atanassov K; Taneva SG Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):409-417. PubMed ID: 27751955 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease. Raghunathan R; Turajane K; Wong LC Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012563 [TBL] [Abstract][Full Text] [Related]
7. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. Krüger T; Lautenschläger J; Grosskreutz J; Rhode H Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563 [TBL] [Abstract][Full Text] [Related]
8. Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells. Lualdi M; Casale F; Rizzone MG; Zibetti M; Monti C; Colugnat I; Calvo A; De Marco G; Moglia C; Fuda G; Comi C; Chiò A; Lopiano L; Fasano M; Alberio T ACS Chem Neurosci; 2023 Dec; 14(23):4240-4251. PubMed ID: 37939393 [TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. Nardo G; Pozzi S; Pignataro M; Lauranzano E; Spano G; Garbelli S; Mantovani S; Marinou K; Papetti L; Monteforte M; Torri V; Paris L; Bazzoni G; Lunetta C; Corbo M; Mora G; Bendotti C; Bonetto V PLoS One; 2011; 6(10):e25545. PubMed ID: 21998667 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders. Kułakowska A; Tarasiuk J; Kapica-Topczewska K; Chorąży M; Pogorzelski R; Kulczyńska-Przybik A; Mroczko B; Bucki R Adv Clin Exp Med; 2018 Aug; 27(8):1075-1080. PubMed ID: 29905407 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. Pansarasa O; Garofalo M; Scarian E; Dragoni F; Garau J; Di Gerlando R; Diamanti L; Bordoni M; Gagliardi S Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269723 [TBL] [Abstract][Full Text] [Related]
12. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Zubiri I; Lombardi V; Bremang M; Mitra V; Nardo G; Adiutori R; Lu CH; Leoni E; Yip P; Yildiz O; Ward M; Greensmith L; Bendotti C; Pike I; Malaspina A Mol Neurodegener; 2018 Nov; 13(1):60. PubMed ID: 30404656 [TBL] [Abstract][Full Text] [Related]
13. Altered Thermal Behavior of Blood Plasma Proteome Related to Inflammatory Cytokines in Early Pregnancy Loss. Komsa-Penkova R; Danailova A; Krumova S; Georgieva G; Giosheva I; Gartcheva L; Iliev I; Gartchev E; Kercheva K; Savov A; Todinova S Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955896 [TBL] [Abstract][Full Text] [Related]
14. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis. Carlomagno C; Banfi PI; Gualerzi A; Picciolini S; Volpato E; Meloni M; Lax A; Colombo E; Ticozzi N; Verde F; Silani V; Bedoni M Sci Rep; 2020 Jun; 10(1):10175. PubMed ID: 32576912 [TBL] [Abstract][Full Text] [Related]
15. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Collins MA; An J; Hood BL; Conrads TP; Bowser RP J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960 [TBL] [Abstract][Full Text] [Related]
16. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Goldknopf IL; Sheta EA; Bryson J; Folsom B; Wilson C; Duty J; Yen AA; Appel SH Biochem Biophys Res Commun; 2006 Apr; 342(4):1034-9. PubMed ID: 16516157 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Neurodegenerative Diseases. Jeromin A; Bowser R Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995 [TBL] [Abstract][Full Text] [Related]
18. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Wuolikainen A; Jonsson P; Ahnlund M; Antti H; Marklund SL; Moritz T; Forsgren L; Andersen PM; Trupp M Mol Biosyst; 2016 Apr; 12(4):1287-98. PubMed ID: 26883206 [TBL] [Abstract][Full Text] [Related]
19. Microcalorimetry of blood serum proteome: a modified interaction network in the multiple myeloma case. Todinova S; Krumova S; Gartcheva L; Robeerst C; Taneva SG Anal Chem; 2011 Oct; 83(20):7992-8. PubMed ID: 21928840 [TBL] [Abstract][Full Text] [Related]
20. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Kori M; Aydın B; Unal S; Arga KY; Kazan D OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]